Hematopoietic stem cell transplantation (HSCT) from a mismatched unrelated donor, an haploidentical donor or a cord blood unit (CBU) has become a widely aviable approach if patient lacks a matched related or unrelated donor.
and > 10.000 as very high levels corresponding to the mismatched donor HLA antigen 3, 4 Thus, if the patient has donor-specific anti-HLA antibodies against antigens present in the mismatched donor or CBU, this option should be disregarded due to the high risk of graft failure (GF) 3, 5, 6 , .
The risk of GF in the presence of DSAs is approximately 70% after T-cell replete and T-cell deplete haplo-HSCT and after CBU transplants. Similarly, after mMUD transplant the risk is between 11 to 22% 3, 5, 6, 7 In an attempt to reduce DSAs, desensitization In Table 1 strategy together with the registry should be taken to select mMUD to which a patient has no DSAs.
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